Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
Design Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.32.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | SR One Capital Simeon George | 6,526,476 | $21,994,224 | 4.77% | |
2. | Logos Capital Arsani William | 4,217,627 | $14,213,403 | 1.57% | |
3. | Point72 Asset Management Steve Cohen | 1,807,218 | $6,090,326 | -1% | 0.01% |
4. | Tang Capital Management Kevin C. Tang | 1,780,975 | $6,001,886 | +6% | 0.3% |
5. | Baker Bros. Advisors Julian Baker And Felix Baker | 1,712,882 | $5,772,412 | -2% | 0.06% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.74 | 17,809 | $66,605.66 | 26,965 | 2024-03-25 | Filing | |
$3.62 | 9,156 | $33,132.82 | 9,156 | 2024-03-22 | Filing | |
$3.74 | 1,300 | $4,865.77 | 1,300 | 2024-03-25 | Filing | |
$2.35 | 21,000 | $49,287.00 | 133,024 | 2023-09-29 | Filing | |
$20.00 | 700,000 | $14,000,000.00 | 700,000 | 2021-03-30 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$5.25 | 217,627 | $1,142,541.75 | 1,000,000 | 2025-08-13 | Filing | |
$5.25 | 345,000 | $1,811,250.00 | 2,655,000 | 2025-08-13 | Filing | |
$6.27 | 3,806 | $23,863.62 | 20,000 | 2024-12-18 | Filing | |
$4.25 | 814,874 | $3,463,214.50 | 0 | 2024-08-09 | Filing | |
$18.63 | 1,455 | $27,105.49 | 4,129,950 | 2022-03-22 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 2,395,743 | $8,073,655 | 0% | |
2. | 1,953,547 | $6,583,453 | 0.26% | |
3. | 1,471,574 | $4,959,204 | 0% | |
4. | 951,198 | $3,205,537 | 0% | |
5. | 794,008 | $2,676,302 | 0% |